{"nct_id":"NCT02259088","title":"A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients","status":"COMPLETED","status_verified_date":"2019-01","start_date":"2014-11-05","start_date_type":"ACTUAL","primary_completion_date":"2017-01-17","primary_completion_date_type":"ACTUAL","completion_date":"2017-01-17","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}